Cerecor, Inc. (CERC) and Aspire Capital Fund Enter into Stock Purchase Agreement worth $15 Million
Cerecor, Inc. (NASDAQ: CERC) and Aspire Capital Fund, LLC ("Aspire") have entered into common stock purchase and registration rights agreements worth $15 million. Cerecor is a clinical-stage biopharmaceutical company specializing in developing drugs that can help people with neurological and psychiatric disorders. Aspire is an institutional investor organization based in Chicago. The agreement covers Aspire’s purchase of $1 million worth of Cerecor common stocks at a rate of $4 per share. This initial purchase is a 4% premium over the September 8 closing stock price of $3.86. The remaining $14 million will be paid by Aspire if Cerecor decides to…